Leiras recognises Inlicensing and partnering as one the key components of our drive to deliver novel therapeutics to the market. While our major in-licensing focus is to support our strategic focus areas (gastroenterology, hypertension, diabetes, respiratory and inflammatory disease, pain, osteoporosis and tissue management) we are eager to evaluate and inlicense commercially rational products falling outside these areas as well.
Our national wide sales and logistics network and our regulatory expertise ensures eliable delivery and a smooth handling of necessary paperwork.
In 2009, total number of products was 201.
Please read more about our areas of interest